Table 1 demographic and clinical data (means ± SD) of patients with Parkinson’s disease
All patients | Females (20) | Males (28) | p | |
|---|---|---|---|---|
Age at onset | 56.5 ± 10 | 58.4 ± 12 | 55.2 ± 8.4 | 0.4 |
Age at interview | 62.7 ± 10.6 | 65.4 ± 12 | 60.8 ± 9.2 | 0.3 |
Disease Duration | 6.2 ± 4.2 | 6.8 ± 4.4 | 5.7 ± 4.2 | 0.2 |
Onset | ||||
Tremor | 32/48 (66.7%) | 13/20 (65%) | 19/28 (68%) | 0.8 |
Rigid-akinetic | 16/48 (33.3%) | 7/20 (35%) | 9/28 (32%) | |
UPDRS-I | 2.3. ± 2.1 | 2.4 ± 2.1 | 2.3 ± 2.2 | 0.9 |
UPDRS-II | 9.8 ± 7.1 | 9.5 ± 6.6 | 10 ± 7.0 | 0.9 |
UPDRS-III | 17. 1 ± 11.4 | 16.6 ± 8.7 | 17.5 ± 13.7 | 0.8 |
UPDRS tot | 29.3 ± 20.1 | 29 ± 17.9 | 29.6 ± 21.9 | 0.9 |
LED | 518.4 ± 398.5 | 496. 4 ± 411.8 | 534.2 ± 402.4 | 0.7 |
Levodopa | 354.6 ± 329.3 | 343.4 ± 309.8 | 352.6 ± 347. 9 | 0.8 |
Dopa agonists | 169.9 ± 129.8 | 152. 9 ± 130.3 | 182.1 ± 131.8 | 0.4 |
PDSS | 112. 9 ± 22 | 113.8 ± 25.6 | 112.3 ± 19.3 | 0.8 |
MMSE | 28 ± 2 | 28.2 ± 2.2 | 28 ± 2.0 | 0.6 |
BDI | 9 ± 7 | 9.7 ± 7 | 8.4 ± 7.1 | 0.5 |
NPI | 10.7 ± 9.5 | 11.4 ± 10.3 | 9.9. ± 8.9 | 0.6 |
SCOPA-AUT tot | 14.1 ± 6.9 | 15.1 ± 6.3 | 13.5 ± 7.4 | 0.4 |
SCOPA-U subscores | 5.2 ± 3.8 | 4.8 ± 3.6 | 5.5 ± 4.4 | 0.5 |
Maximum flow rate | 17.9 ± 9.1 | 21.9 ± 12 | 15.4 ± 6 | 0.03 |
Postvoid residual | 24.4 ± 44.2 | 18.9 ± 44.4 | 28.3 ± 44.4 | 0.5 |